182 related articles for article (PubMed ID: 8473644)
1. Aspirin, but not heparin, suppresses the transient increase in thromboxane biosynthesis associated with cardiac catheterization or coronary angioplasty.
Ciabattoni G; Ujang S; Sritara P; Andreotti F; Davies G; Simonetti BM; Patrono C; Maseri A
J Am Coll Cardiol; 1993 May; 21(6):1377-81. PubMed ID: 8473644
[TBL] [Abstract][Full Text] [Related]
2. Continued thromboxane A2 formation despite administration of a platelet glycoprotein IIb/IIIa antagonist in patients undergoing coronary angioplasty.
Byrne A; Moran N; Maher M; Walsh N; Crean P; Fitzgerald DJ
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3224-9. PubMed ID: 9409315
[TBL] [Abstract][Full Text] [Related]
3. Effects of unfractionated and low molecular weight heparins on platelet thromboxane biosynthesis "in vivo".
Landolfi R; De Candia E; Rocca B; Ciabattoni G; Antinori A; Masetti R; Patrono C
Thromb Haemost; 1994 Dec; 72(6):942-6. PubMed ID: 7740468
[TBL] [Abstract][Full Text] [Related]
4. Increased thromboxane biosynthesis in patients with polycythemia vera: evidence for aspirin-suppressible platelet activation in vivo.
Landolfi R; Ciabattoni G; Patrignani P; Castellana MA; Pogliani E; Bizzi B; Patrono C
Blood; 1992 Oct; 80(8):1965-71. PubMed ID: 1327286
[TBL] [Abstract][Full Text] [Related]
5. Thromboxane biosynthesis in cardiovascular diseases.
Patrono C; Ciabattoni G; Davi G
Stroke; 1990 Dec; 21(12 Suppl):IV130-3. PubMed ID: 2260137
[TBL] [Abstract][Full Text] [Related]
6. Thromboxane biosynthesis and platelet function in type II diabetes mellitus.
Davì G; Catalano I; Averna M; Notarbartolo A; Strano A; Ciabattoni G; Patrono C
N Engl J Med; 1990 Jun; 322(25):1769-74. PubMed ID: 2345567
[TBL] [Abstract][Full Text] [Related]
7. Differential suppression of thromboxane biosynthesis by indobufen and aspirin in patients with unstable angina.
Cipollone F; Patrignani P; Greco A; Panara MR; Padovano R; Cuccurullo F; Patrono C; Rebuzzi AG; Liuzzo G; Quaranta G; Maseri A
Circulation; 1997 Aug; 96(4):1109-16. PubMed ID: 9286937
[TBL] [Abstract][Full Text] [Related]
8. Urinary excretion and origin of 11-dehydro-2,3-dinor-thromboxane B2 in man.
Chiabrando C; Rivoltella L; Alberti E; Bonollo M; Djurup R; Fanelli R
Prostaglandins; 1993 May; 45(5):401-11. PubMed ID: 8321910
[TBL] [Abstract][Full Text] [Related]
9. Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus.
Santilli F; Davì G; Consoli A; Cipollone F; Mezzetti A; Falco A; Taraborelli T; Devangelio E; Ciabattoni G; Basili S; Patrono C
J Am Coll Cardiol; 2006 Jan; 47(2):391-7. PubMed ID: 16412866
[TBL] [Abstract][Full Text] [Related]
10. 11-dehydro thromboxane B2 levels after percutaneous transluminal angioplasty in patients with peripheral arterial occlusive disease during a one year follow-up period.
Maga P; Sanak M; Jawien J; Rewerska B; Maga M; Wachsmann A; Koziej M; Gregorczyk-Maga I; Nizankowski R
J Physiol Pharmacol; 2016 Jun; 67(3):377-83. PubMed ID: 27511998
[TBL] [Abstract][Full Text] [Related]
11. Circulating myeloid-related protein-8/14 is related to thromboxane-dependent platelet activation in patients with acute coronary syndrome, with and without ongoing low-dose aspirin treatment.
Santilli F; Paloscia L; Liani R; Di Nicola M; Di Marco M; Lattanzio S; La Barba S; Pascale S; Mascellanti M; Davì G
J Am Heart Assoc; 2014 Jul; 3(4):. PubMed ID: 25037196
[TBL] [Abstract][Full Text] [Related]
12. Urinary 11-dehydro-thromboxane B2: a quantitative index of platelet activation in cerebral infarction.
Uyama O; Shimizu S; Nakanishi T; Nakahama H; Takiguchi A; Hayashi Y; Yamamoto S; Sugita M
Intern Med; 1992 Jun; 31(6):735-9. PubMed ID: 1392173
[TBL] [Abstract][Full Text] [Related]
13. Increased thromboxane biosynthesis in essential thrombocythemia.
Rocca B; Ciabattoni G; Tartaglione R; Cortelazzo S; Barbui T; Patrono C; Landolfi R
Thromb Haemost; 1995 Nov; 74(5):1225-30. PubMed ID: 8607099
[TBL] [Abstract][Full Text] [Related]
14. Thromboxane A2 synthesis in pregnancy-induced hypertension.
Fitzgerald DJ; Rocki W; Murray R; Mayo G; FitzGerald GA
Lancet; 1990 Mar; 335(8692):751-4. PubMed ID: 1969511
[TBL] [Abstract][Full Text] [Related]
15. Aspirin reload before elective percutaneous coronary intervention: impact on serum thromboxane b2 and myocardial reperfusion indexes.
Basili S; Tanzilli G; Raparelli V; Calvieri C; Pignatelli P; Carnevale R; Dominici M; Placanica A; Arrivi A; Farcomeni A; Barillà F; Mangieri E; Violi F
Circ Cardiovasc Interv; 2014 Aug; 7(4):577-84. PubMed ID: 25074252
[TBL] [Abstract][Full Text] [Related]
16. What is the lowest dose of aspirin for maximum suppression of in vivo thromboxane production after a transient ischemic attack or ischemic stroke?
Dippel DW; Van Kooten F; Leebeek FW; van Vliet HH; Mehicevic A; Li SS; Koudstaal PJ
Cerebrovasc Dis; 2004; 17(4):296-302. PubMed ID: 15026612
[TBL] [Abstract][Full Text] [Related]
17. Thromboxane and prostacyclin biosynthesis in patients with acute spontaneous intracerebral hemorrhage.
Saloheimo P; Juvela S; Riutta A; Pyhtinen J; Hillbom M
Thromb Res; 2005; 115(5):367-73. PubMed ID: 15733969
[TBL] [Abstract][Full Text] [Related]
18. Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo. Evidence derived from the study of peripheral arterial disease.
Davì G; Gresele P; Violi F; Basili S; Catalano M; Giammarresi C; Volpato R; Nenci GG; Ciabattoni G; Patrono C
Circulation; 1997 Jul; 96(1):69-75. PubMed ID: 9236419
[TBL] [Abstract][Full Text] [Related]
19. Aspirin dosage and thromboxane synthesis in patients with vascular disease.
Hart RG; Leonard AD; Talbert RL; Pearce LA; Cornell E; Bovill E; Feinberg WM
Pharmacotherapy; 2003 May; 23(5):579-84. PubMed ID: 12741431
[TBL] [Abstract][Full Text] [Related]
20. Thromboxane biosynthesis in allergen-induced bronchospasm. Evidence for platelet activation.
Lupinetti MD; Sheller JR; Catella F; Fitzgerald GA
Am Rev Respir Dis; 1989 Oct; 140(4):932-5. PubMed ID: 2508524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
